Quality of life and symptom treatment response in postmenopausal women with advanced breast cancer (ABC) receiving Fulvestrant after progression on prior antiestrogen therapy

被引：0
|
作者：
Kalyadina, S. [1 ]
Novik, A. [2 ]
Ionova, T. [1 ]
机构：
[1] Multinat Ctr Qual Life Res, St Petersburg, Russia
[2] Pirogov Natl Med Surg Ctr, Moscow, Russia
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70666-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [1] QUALITY OF LIFE RESPONSE IN WOMEN WITH ADVANCED BREAST CANCER RECEIVING FASLODEX (FULVESTRANT) AFTER PROGRESSION ON PRIOR ANTIESTROGEN THERAPY
    Novik, A. A.
    Ionova, T. I.
    Kalyadina, S. A.
    Kishtovich, A. V.
    ANNALS OF ONCOLOGY, 2008, 19 : 75 - 75
  • [2] Endocrine response after prior treatment with fulvestrant (Fasiodex®) in postmenopausal women with advanced breast cancer
    Cheung, K
    Robertson, JFR
    Scott, N
    Owers, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S98 - S99
  • [3] Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre
    Cheung, KL
    Owers, R
    Robertson, JFR
    ENDOCRINE-RELATED CANCER, 2006, 13 (01) : 251 - 255
  • [4] CLINICAL BENEFIT OF FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER ACCORDING TO PRIOR THERAPY
    De Angelis, Carmine
    Cerillo, Ivana
    Ruocco, Raffaella
    Stanzione, Brigida
    Milano, Monica
    Gargiulo, Piera
    Lauria, Rossella
    Bruzzese, Dario
    Arpino, Grazia
    De Placido, Sabino
    BREAST, 2013, 22 : S44 - S44
  • [5] Fulvestrant in the treatment of postmenopausal women with advanced breast cancer
    Gradishar, W
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (03) : 445 - 453
  • [6] Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer according to prior therapy.
    De Angelis, Carmine
    Cerillo, Ivana
    Ruocco, Raffaella
    Bruzzese, Dario
    Forestieri, Valeria
    Lauria, Rossella
    Stanzione, Brigida
    Paciolla, Immacolata
    De Laurentiis, Michelino
    De Placido, Sabino
    Arpino, Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Fulvestrant (faslodex) in women with advanced breast cancer after progression on prior anti-estrogenic therapy:: Our experience
    Fusco, O.
    Malugani, F.
    Menatti, E.
    Berardi, E.
    Fiumano, M.
    Visini, M.
    Ciotti, R.
    Ardizzoia, A.
    Colombo, I
    Villa, F.
    Giordano, M.
    Isa, L.
    Comande, M.
    Bertolini, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI14 - XI14
  • [8] Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: A Japanese study
    Watanabe, T
    Sano, M
    Ohno, S
    Inaji, H
    Nishimura, R
    Shin, E
    Nomura, Y
    Morris, C
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1275 - 1280
  • [9] Fulvestrant in postmenopausal women with locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy: a guide
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2015, 31 (10) : 323 - 328
  • [10] FULVESTRANT AS FIRST-LINE TREATMENT FOR ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN AFTER PROGRESSION ON PRIOR ADJUVANT THERAPY WITH THIRD-GENERATION AROMATASE INHIBITORS: A PHASE II TRIAL
    Palumbo, R.
    Bernardo, A.
    Strada, M. R.
    Teragni, C.
    Poggi, G.
    Frascaroli, M.
    Jedrychowska, I.
    Amatu, A.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 71 - 71
12345